Sanofi stock heads into the open after a 1.1 percent rise

At the close on September 22, 2026, Sanofi stock stood near USD 42.50 on Nasdaq, while the Nasdaq Composite gained 2.26 percent. Sanofi also held near its 52-week low of USD 40.89. A UBS pharma event is scheduled today.

Sanofi stock closed near USD 42.50 on Nasdaq on September 22, 2026, up approximately 1.1 percent. The shares lagged the Nasdaq Composite, which gained 2.26 percent to 27,243.24 points in the same session. Sanofi is scheduled to appear at a UBS pharma event today.

September 22, 2026 in numbers

Sanofi S.A. (ISIN FR0000120578) traded near USD 42.50 at the Nasdaq close on September 22, 2026. The stock was near its 52-week low of USD 40.89 and was down roughly 9 percent year to date, according to the dated session report.

As Investing.com reported on September 22, 2026, Sanofi used the Bank of America Global Healthcare Conference to present a research and development reset under new leadership. Management also said the next strategic update is expected with third-quarter earnings in October.

UBS pharma event today

Sanofi is scheduled to participate in the UBS Pharma Bus Tour in Paris on September 23, 2026, with Chief Executive Officer Belén Garijo and Chief Scientific Officer Mike Quigley, according to Sanofi. The company event follows the prior session's research and development update and may provide further company commentary before the next quarterly reporting update.